[
  {
    "ts": "2025-08-03T13:16:22+00:00",
    "headline": "Regeneron Pharmaceuticals Second Quarter 2025 Earnings: Beats Expectations",
    "summary": "Regeneron Pharmaceuticals ( NASDAQ:REGN ) Second Quarter 2025 Results Key Financial Results Revenue: US$3.68b (up 3.6...",
    "url": "https://finance.yahoo.com/news/regeneron-pharmaceuticals-second-quarter-2025-131622391.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "fbf8272a-c4c0-3a08-bd7b-b57f23ce520c",
      "content": {
        "id": "fbf8272a-c4c0-3a08-bd7b-b57f23ce520c",
        "contentType": "STORY",
        "title": "Regeneron Pharmaceuticals Second Quarter 2025 Earnings: Beats Expectations",
        "description": "",
        "summary": "Regeneron Pharmaceuticals ( NASDAQ:REGN ) Second Quarter 2025 Results Key Financial Results Revenue: US$3.68b (up 3.6...",
        "pubDate": "2025-08-03T13:16:22Z",
        "displayTime": "2025-08-03T13:16:22Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c",
          "originalWidth": 945,
          "originalHeight": 636,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/uJL6bHu6ZvrkfEMEXrej0w--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c.cf.webp",
              "width": 945,
              "height": 636,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6q7m4tTcuA7S9BaxIiz0Jw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/regeneron-pharmaceuticals-second-quarter-2025-131622391.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/regeneron-pharmaceuticals-second-quarter-2025-131622391.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "REGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-08-03T10:00:00+00:00",
    "headline": "2 Biotech Stocks That Could Soar 29% and 165% According to Wall Street's Top Analysts",
    "summary": "These biotech businesses look compelling for very different reasons.",
    "url": "https://www.fool.com/investing/2025/08/03/2-biotech-stocks-that-could-soar-29-and-165-accord/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "e9a099e8-a330-30ef-86b1-dfd77415a264",
      "content": {
        "id": "e9a099e8-a330-30ef-86b1-dfd77415a264",
        "contentType": "STORY",
        "title": "2 Biotech Stocks That Could Soar 29% and 165% According to Wall Street's Top Analysts",
        "description": "",
        "summary": "These biotech businesses look compelling for very different reasons.",
        "pubDate": "2025-08-03T10:00:00Z",
        "displayTime": "2025-08-03T10:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/b689663ed9d74b745fd1f749385fe7d8",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "Young professionals in an office smiling and reviewing paperwork.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/czIN1hkguzotDpjEFcZk0g--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/b689663ed9d74b745fd1f749385fe7d8.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/POWbAAkavdUDVCtHn4jCMQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/b689663ed9d74b745fd1f749385fe7d8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/08/03/2-biotech-stocks-that-could-soar-29-and-165-accord/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/2-biotech-stocks-could-soar-100000466.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VKTX"
            },
            {
              "symbol": "REGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]